COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs. - Test2 - elhamkhani - TriplyDB

COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs.

COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs.

http://www.wikidata.org/entity/Q38123175

about

Modulators affecting the immune dialogue between human immune and colon cancer cells Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice.Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention An investigation of the rate of cyclooxygenase-2 expression on the surface of adenomatous and colorectal adenocarcinoma polyps Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent Lymphadenectomy promotes tumor growth and cancer cell dissemination in the spontaneous RET mouse model of human uveal melanoma.A Nonselective Cyclooxygenase Inhibitor Enhances the Activity of Vinblastine in a Naturally-Occurring Canine Model of Invasive Urothelial Carcinoma.Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells.NSAIDs inhibit tumorigenesis, but how?A clinical perspective on the role of chronic inflammation in gastrointestinal cancer.Mechanistic Role of MicroRNA in Cancer Chemoprevention by Nonsteroidal Anti-inflammatory Drugs.Indomethacin promotes apoptosis in gastric cancer cells through concomitant degradation of Survivin and Aurora B kinase proteins.Radioprotective effect of mefenamic acid against radiation-induced genotoxicity in human lymphocytes.COX-2 inhibitor NS-398 suppresses doxorubicin-induced p53 accumulation through inhibition of ROS-mediated Jnk activation.5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.Amine Containing Analogs of Sulindac for Cancer Prevention.Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors.

P2860

Q33612663-EC307538-57E9-4A52-9B08-F916F2A5DD3A Q35845857-055ACFD8-313B-4D84-9D3D-3C51F6632CDD Q35859243-8CA2C299-C1E7-4533-B50A-DFA71482CD89 Q36206364-95CD6C82-D188-40DC-A1DE-FF9C9F8F2724 Q36347346-3BB71458-E026-4732-8FCB-F704F2E6C481 Q36483712-380AA816-03CE-4FE2-AD4A-835E2324E939 Q36689098-0E9774FC-2C80-4C10-89D7-2D342E97424C Q37053781-6D36FCD9-F66C-441A-824E-939DDAED4752 Q37708833-33376C1D-B815-4172-99D8-9B691669C302 Q37716398-044D48B8-CFCE-4BA6-9EBB-B3A282728783 Q38169133-1D4CA1EE-8F94-4C3A-9409-D338F44C5D2C Q38241837-D299183C-DCF9-47C5-A3AE-173D220D09A2 Q38554955-48C93497-A70F-4C51-AEFE-A295D770725B Q38990415-EECC493D-BC82-4CEB-9D39-AB03283463AA Q43217946-FF9EE7FA-BBEE-4E42-B22E-D13EAA5E5F10 Q46611970-FC03326E-D7CF-4BF5-B723-FFC0896E5875 Q48110321-0DDB7C05-600C-4D27-9C52-094FDB309EAF Q50324421-182CE1DE-37F3-4C7C-8886-4A62C88112CA Q50334520-06D18B0F-BE5D-4FEA-80E1-AE75A9DB1CE4

P2860

COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs.

http://www.wikidata.org/entity/Q38123175

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs.

@en

type

label

COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs.

@en

prefLabel

COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs.

@en

P1433

Q38123175-80A609F6-3E5C-4B21-BAD0-7E03E5DA0FCE

P1476

Q38123175-42C2FDA3-D350-4674-8372-EFCF0B801048

P2093

Q38123175-433BC29F-E656-465D-8E24-61C5A4D393DD

Q38123175-926066A9-38C2-4500-A047-0A09E5D28BB8

Q38123175-AAFFD302-36A1-408A-9600-4EF7210BE845

P2860

Q38123175-00554AB2-7A8D-4C40-B7BF-A1AB7C58CF45

Q38123175-01E17803-2238-4505-BC32-1C823AB66A4C

Q38123175-0216B3D9-920F-4D6C-8485-8D404DE30C0D

Q38123175-040596D8-D09A-46B3-9DA9-6374A73EF501

Q38123175-04ADA6B4-1FE7-4BE5-822D-99F7FDC6A1F6

Q38123175-0615BC4F-E62F-4620-8AC2-991B8CEDF5CB

Q38123175-078E22A4-F5A1-44AD-B9B5-5FE7DD5B7565

Q38123175-08E73FEA-E644-4C35-9C66-37757893CA1B

Q38123175-09BFF866-0692-4049-B58A-9F73394BA801

Q38123175-09C2ADB3-5C34-476B-ABFE-DE1AEA4F626C

P304

Q38123175-6C9EA551-7F9B-4D36-A3E5-5E1F7D05CD64

P31

Q38123175-9609290E-95A5-47D9-B380-BA07563793DE

P356

Q38123175-0A5359A3-847E-497A-8F1B-7DED4C532A02

P478

Q38123175-DE496CE1-F1C2-4CA9-93BF-F6F5E655C400

P577

Q38123175-0193F915-1DD1-466B-ABB5-8ABF83383681

P5875

Q38123175-97865E69-E905-485C-96AC-9598C55BE622

P698

Q38123175-0F60AF09-63D4-44C3-BB05-0CFF7D056D80

P921

Q38123175-A4910684-88FC-409F-B091-E648E95C381C

P932

Q38123175-DF24A3AC-257F-4767-A157-8278A92E33A2

P356

FONC.2013.00181

P1433

Frontiers in Oncology

P1476

COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs.

@en

P2093

Evrim Gurpinar

http://www.w3.org/2001/XMLSchema#string

Gary A Piazza

http://www.w3.org/2001/XMLSchema#string

William E Grizzle

http://www.w3.org/2001/XMLSchema#string

P2860

Prostacyclin-dependent apoptosis mediated by PPAR delta

NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling

The ancient drug salicylate directly activates AMP-activated protein kinase

Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits

Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells

Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition

Autophagy fights disease through cellular self-digestion

Sulindac inhibits activation of the NF-kappaB pathway

NSAIDs and chemoprevention

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

P304

181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2013.00181

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

250926583

http://www.w3.org/2001/XMLSchema#string

P698

23875171

http://www.w3.org/2001/XMLSchema#string

P921

P932

3708159

http://www.w3.org/2001/XMLSchema#string